Social Media, Mobile, Wearable News & Views
35.5K views | +57 today
Follow
 
Scooped by Pharma Guy
onto Social Media, Mobile, Wearable News & Views
Scoop.it!

Is FDA So Digitally "Flummoxed" It Doesn't Send Out Violation Letters?

Is FDA So Digitally "Flummoxed" It Doesn't Send Out Violation Letters? | Social Media, Mobile, Wearable News & Views | Scoop.it
The FDA last year issued nine infraction letters to drug makers for the way they promoted their products, an all-time low.


The decline may reflect the FDA’s “unfinished work” in formulating guidelines for digital media, according to Mark Senak of the public relations firm Fleishman-Hillard, who writes Eye on FDA. This is an ongoing issue that has flummoxed drug makers, who are grappling with ways to harness social media to reach consumers while trying to avoid regulatory infractions.


Indeed, although drug makers have embraced the Internet — at least, in varying degrees — the FDA has been slow to issue guidelines that might prompt the agency to uncover violations that warrant letters.


One other point worth noting — Eye on FDA writes that, for the past few years, most of the OPDP violation letters “largely involved” drug makers that are “lesser known” and typically have fewer products on the market. Are smaller drug makers bigger risk takers when it comes to promotions? Have the biggest drug makers figured out how to avoid infractions, or are they simply shying away from some efforts?

Pharma Guy's insight:

The pharma companies that received serious WARNING LETTERS as opposed to less serious UNTITLED LETTERS were two Canadian companies. One of these companies was Duchesnay, which received a warning letter for the promotion of Diclegis via Instagram. It should be noted that an American agency was responsible for dreaming up the violative Instagram post. For more on that, read "How Kim Kardashian Got Hired to Shill for Diclegis"; http://bit.ly/kimaudition  

more...
No comment yet.
Social Media, Mobile, Wearable News & Views
What's going on in the world of pharma social media, mobile apps, mHealth, and wearable technology
Curated by Pharma Guy